RH Capital

Indigenous entrepreneurs received only .004% of venture capital funding in 2021. The number of Indigenous women who have received funding is even less. A 2022 industry benchmark survey by Deloitte didn’t even include the statistics for Native American, Alaska Native, or Native Hawaiian venture capitalists in their report, instead folding them into the category for “people of color” or “women of color.” Organizations like the Native American Capital and Investment Alliance "NACIA" are working to bridge the gap between Indigenous startups, entrepreneurs, and equity and debt capital. According to the US Census Bureau, Native American-owned businesses contribute over $33 billion to the US economy every year and employ over 200,000 people. https://lnkd.in/emY2yPj7 #VentureCapital #CapitalMarkets #IndigenousLeaders #IndigenousPeoplesDay

Maven’s $90 million round ???? accounted for 20% of all VC funding for women’s health in 2022. Women-focused health tech ventures still attract just 2% of health tech venture funding. And, ironically (or not), new research has found that women’s health ventures led by women are less likely to get funding than those run by men. Meanwhile, women-focused health tech ventures have weathered the fundraising drought better than the broader health tech sector. https://lnkd.in/gAtmrhdR

Today’s the day ? …the team behind RH Capital has officially launched Foreground Capital, a new venture firm putting women’s health front and center!? While our name may have changed, the same team of Elizabeth Bailey, Stasia Obremskey and Alice Zheng will continue managing RH Capital Funds I/II and supporting our portfolio. We will continue in our board roles, and continue to provide the same resources, value-added services and active partnership that we have over the past 5 years. What’s changing? Aside from our new Foreground emails and titles, we’re gearing up to launch a new fund later this year, with the same laser focus on women’s health innovation and health equity. Rhia Ventures played an instrumental role in incubating and launching RH Capital when investment in women’s health was scarce. We're deeply grateful for their support and proud of what we've achieved together. With a positive market shift, we’re excited to take the next step as an independent venture firm, allowing us to scale, attract new capital, and continue investing in exceptional companies. Rhia Ventures will still support new funding programs under the RH Capital umbrella. Stay in the loop by signing up for our newsletter at https://lnkd.in/dSNgUtkM and following us on LinkedIn for more exciting updates! We look forward to continuing this journey together and can’t wait to share more soon! ?? #womenshealth #healthequity #venturecapital #vc #healthcare #startups

Are men ready for new contraceptive options? Our portfolio company, Contraline asked men about their desire for new birth control methods. Check out this video to hear from the men advocating for innovation in contraception and reproductive equality!

We love quality time with our portfolio companies! Always great to see Kevin Eisenfrats, CEO + Founder of Contraline and Anu Sharma CEO + Founder of Millie! Ft: Alice Zheng, Stasia Obremskey, Elizabeth Bailey

We recently welcomed Novocuff, Inc. to our portfolio and are excited to join Amelia Degenkolb, Donald Lee, and their team on their mission to improve pregnancy outcomes and reduce preterm births. The Novocuff Cervical Control System (CCS) is designed to tackle the complex issues associated with preterm conditions like Preterm Premature Rupture of Membranes (PPROM) and a short cervix. Preterm birth is the leading cause of death for infants under one year old. According to the World Health Organization (WHO), complications from preterm birth were responsible for approximately 1 million deaths in 2020. In case you missed it, Novocuff recently secured $26M in Series A funding: https://lnkd.in/dRbz4KCr. They are now preparing to launch a multi-center pivotal clinical trial in the U.S. in early 2025. Follow their page to stay updated! ?? CC: Alice Zheng, Stasia Obremskey, Elizabeth Bailey

Our Managing Director, Elizabeth Bailey, spoke with the?Financial Times?to discuss data privacy concerns for female fertility tech startups. Thank you Stephanie Stacey for shining a spotlight on this and for including us in this conversation!

Our Principal Alice Zheng will be speaking at HLTH USA this year! We're excited to see Alice take the stage with Frederique Dame, GP and GV (Google Ventures) and Lucy Perez Senior Partner at McKinsey & Company for their discussion "The Under-researched, Under-diagnosed and Overlooked Truth about Women's Health". Stay tuned for more info!

Congratulations Novocuff, Inc.! RH Capital invested in Novocuff's Series A round, supporting the company's mission to improve pregnancy outcomes and reduce the risk of preterm birth.?Novocuff is developing an innovative medical device to address the complexities of?PPROM and short cervix, with the goal of extending pregnancy. AXA Investment Managers, through its Global Healthcare Private Equity Strategy, led the round?alongside significant participation from Laerdal Million Lives Fund, in addition to support from existing and new investors Laborie, Avestria Ventures and March of Dimes. We are excited to be on this journey with you Amelia Degenkolb, Donald Lee and team! Full story in Femtech Insider: CC: Alice Zheng, Stasia Obremskey, Elizabeth Bailey, Kathrin Folkendt

We are proud to lead Seven Starling's Series A round and excited to welcome new investors Zeal Capital Partners, March of Dimes, Fiore Ventures, Ulu Ventures, Rogue Venture Partners,?Graham & Walker,?Wisdom Ventures and continue to work with co-investors Magnify Ventures, Pear VC, Emerson Collective, Expa, and Inflect Health! The funding will be utilized to broaden access to vital women's mental health services, ensuring that more individuals receive the specialized support they need during critical times such as infertility, miscarriage, loss, pregnancy, postpartum, and parenthood. Seven Starling's unique clinical model coupled with a deep understanding of patients' needs and experiences drives superior clinical outcomes, with over 90% of patients seeing a clinically significant improvement in their symptoms upon completing the program. It includes: ? Specialized Individual & Group Therapy: Offering both individual and group therapy sessions led by specialized mental health providers who understand the unique challenges faced by women. ? Medication Management: Providing evidence-based psychiatric evaluation and medication management to support those who can benefit from medication as part of their treatment. ? Care Coordination: Pairing each patient with a Patient Advocate who supports their seamless onboarding process and ensures they get the most out of their experience. ? In-App Content & Exercises: Engaging patients in-between appointments with tailored content such as CBT-inspired exercises, journaling prompts, and guided meditations. If you're looking to get on the ground floor of this incredible startup, find more details here:?https://lnkd.in/dyHVwrYp? Congratulations Tina Keshani, Sophia Richter, Julia A. Colea and team! Check out the exclusive in Axios by Aaron Weitzman: CC: Elizabeth Bailey, Stasia Obremskey, Alice Zheng